Steatosis is a cofactor in liver injury in hemochromatosis

被引:133
作者
Powell, EE
Ali, A
Clouston, AD
Dixon, JL
Lincoln, DJ
Purdie, DM
Fletcher, LM
Powell, LW
Jonsson, JR
机构
[1] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[3] Princess Alexandra Hosp, Nutr & Dietet Serv, Brisbane, Qld 4102, Australia
[4] Queensland Inst Med Res, Populat Studies & Human Genet Div, Brisbane, Qld 4006, Australia
[5] No Calif Canc Ctr, Fremont, CA USA
[6] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1053/j.gastro.2005.09.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Obesity-related steatosis is an increasingly common histologic finding and often coexists with other chronic liver diseases. Although obesity and steatosis are recognized risk factors for more advanced fibrosis in chronic hepatitis C and alcoholic liver disease, it has not been determined whether these factors influence the progression of other diseases in which steatosis is not a feature of the primary liver insult. Methods: We studied 214 patients with hemochromatosis who were homozygous for the C282Y substitution in HFE and had undergone liver biopsy prior to phlebotomy. Results: Steatosis was present in 41.1% of these patients, and 14.5% had moderate or severe steatosis. Median serum alanine aminotransferase (ALT) and ferritin levels were higher (P < .001), and median transferrin saturation (P = .01) and hepatic iron concentration (HIC) were lower (P = .003) in subjects with steatosis compared with subjects without steatosis. Bivariate analysis revealed a significant association between steatosis and fibrosis (P = .001). Following multiple logistic regression, steatosis was independently associated with fibrosis (odds ratio [OR] 4.3, 95% confidence interval [CI]: 2.1 - 8.8; P < .001) along with male sex (OR, 5.1; 95% CI: 2.0 - 12.5; P < .001), excess alcohol consumption (males >= 50 g/day, females >= 40 g/day) (OR, 3.9; 95% CI: 1.8 - 8.5; P = .001), and hepatic iron content (OR, 1.4; 95% CI: 1.2 - 1.6; P < .001). Both higher BMI (OR, 3.3; 95% CI: 1.8 - 6.3; P < .001) and alcohol consumption (males >= 30 g/day, females :10 g/day) (OR, 3.4; 95% CI: 1.2 - 10.0; P = .023) were independently associated with the presence of steatosis. Conclusions: These findings indicate that obesity-related steatosis may have a role as a cofactor in liver injury in hemochromatosis. This has important clinical implications and suggests that obesity should be actively addressed in the management of patients with hemochromatosis, as well as other liver diseases.
引用
收藏
页码:1937 / 1943
页数:7
相关论文
共 37 条
[1]   Hemochromatosis and iron-overload screening in a racially diverse population [J].
Adams, PC ;
Reboussin, DM ;
Barton, JC ;
McLaren, CE ;
Eckfeldt, JH ;
McLaren, GD ;
Dawkins, FW ;
Acton, RT ;
Harris, EL ;
Gordeuk, VR ;
Leiendecker-Foster, C ;
Speechley, M ;
Snively, BM ;
Holup, JL ;
Thomson, E ;
Sholinsky, P ;
Acton, RT ;
Barton, JC ;
Dixon, D ;
Rivers, CA ;
Tucker, D ;
Ware, JC ;
McLaren, CE ;
McLaren, GD ;
Anton-Culver, H ;
Baca, JA ;
Bent, TC ;
Brunner, LC ;
Dao, MM ;
Jorgensen, KS ;
Kuniyoshi, J ;
Le, HD ;
Masatsugu, MK ;
Meyskens, FL ;
Morohashi, D ;
Nguyen, HP ;
Panagon, SN ;
Phung, C ;
Raymundo, V ;
Ton, T ;
Walker, AP ;
Wenzel, LB ;
Ziogas, A ;
Adams, PC ;
Bloch, E ;
Chakrabarti, S ;
Fleischhauer, A ;
Harrison, H ;
Jia, K ;
Larson, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1769-1778
[2]  
Adams PC, 2001, AM J GASTROENTEROL, V96, P567
[3]   Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[4]  
Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1
[5]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[6]   The epidemiology of fatty liver [J].
Bellentani, S ;
Bedogni, G ;
Miglioli, L ;
Tiribelli, C .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (11) :1087-1093
[7]   The spectrum of liver disease in the general population: lesson from the Dionysos study [J].
Bellentani, S ;
Tiribelli, C .
JOURNAL OF HEPATOLOGY, 2001, 35 (04) :531-537
[8]   Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA [J].
Beutler, E ;
Felitti, VJ ;
Koziol, JA ;
Ho, NJ ;
Gelbart, T .
LANCET, 2002, 359 (9302) :211-218
[9]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[10]   DIRECT EVIDENCE FOR INVIVO HYDROXYL-RADICAL GENERATION IN EXPERIMENTAL IRON OVERLOAD - AN ESR SPIN-TRAPPING INVESTIGATION [J].
BURKITT, MJ ;
MASON, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8440-8444